Dr. Axel Hamann

Born 1974.

Education:

• 1999: Law studies at the University of Wuerzburg, First State Examination

• 2002: Studies of Business Administration at the University of Cologne, Degree: PhD

• 2003: Second State Examination at the Higher Regional Court OLG Duesseldorf

• 2010: Executive MBA Finance, Kellog School of Management, NW University (USA)

Career:

• 2003 - 2005: Senior Associate, Hengeler Mueller

• 2005 - 2007: Head of Legal M&A, Bayer AG

• 2007 - 2010: Executive Board Support, Finance

• 2010 - 2014: CEO and CFO, Bayer Turkey

• 2014 - 2015: Global Project lead IPO and Carve-out "Covestro"

• 2016 - 2018: Head of Bayer Business Consulting

• 2019 - 2020: Project lead of the restructuring program "Bayer 2022"

• 2020 - 2022: CFO, Bayer Pharmaceuticals

• 2023 - 2025: Head of Internal Audit & Risk Management, Head of Global M&A, Bayer AG

• since May 1, 2025: Member of the Executive Board, thyssenkrupp AG